Auteur M. B. KLEIN

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?

C. LANIECE DELAUNAY ; A. GODIN ; N. KRONFLI ; D. PANAGIOTOGLOU ; J. COX ; M. ALARY ; M. B. KLEIN ; M. MAHEU-GIROUX | 2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique

Background: In high-income countries, people who inject drugs (PWID) are a priority population for eliminating hepatitis C virus (HCV) by 2030. Despite evidence informing micro-elimination strategies, little is known regarding efforts needed to [...]

Plus d'info

Ajouter à la sélection

Lien externe

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

J. GREBELY ; G. J. DORE ; S. MORIN ; J. K. ROCKSTROH ; M. B. KLEIN | 2017
Dans Journal of the International AIDS Society (Vol.20, n°22146, August 2017) Article : Périodique

INTRODUCTION: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverag[...]

Plus d'info

Ajouter à la sélection

Lien externe